Junxian Yu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Helicobacter Pylori Infection

Advanced Non Small Cell Lung Cancer

Randomized Controlled Trial

Epidermal Growth Factor Receptor

Top Venues

The clinical respiratory journal

Disease markers

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Lin Zhang, Wei Chen, Hongtao Wei, Junxian Yu
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with KRAS mutations: A network meta-analysis. The clinical respiratory journal 18 (4) (2024)
Lin Zhang, Wei Chen, Hongtao Wei, Junxian Yu
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with KRAS mutations: A network meta-analysis. The clinical respiratory journal 18 (4) (2024)
Wei Chen, Ling Li, Sheng Cheng, Junxian Yu
The Efficacy of Immune Checkpoint Inhibitors vs. Chemotherapy for KRAS-Mutant or EGFR-Mutant Non-Small-Cell Lung Cancers: A Meta-Analysis Based on Randomized Controlled Trials. Disease markers 2022 (2022)
Lingye Zhang, Juan Liu, Fandong Meng, Yingying Guan, Yongjun Wang, Shengtao Zhu, Yaqiong Liu, Qing Xie, Junxian Yu, Shu Tian Zhang
Pharmacokinetics of Bismuth following Oral Administration of Wei Bi Mei in Healthy Chinese Volunteers. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)